• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MDS Appoints New CEO, Announces Changes to Executive Team

MDS Appoints New CEO, Announces Changes to Executive Team

January 8, 2010
CenterWatch Staff

MDS has appointed chief operating officer Steve West as CEO, replacing Stephen DeFalco.

West is president of MDS Nordion, which became MDS’ primary business unit after the company launched a strategic repositioning effort last summer.  

The Toronto-based company sold MDS Analytical Technologies and its late-stage contract research business in 2009 and has been seeking a buyer for its early-stage contract research unit, MDS Pharma Services, for several months. MDS Nordion will become MDS’ premier business line once a suitable buyer is found.

The company also announced that Peter Dans, MDS Nordion’s senior vice president, finance, will become the company’s chief financial officer (CFO) February 1. Current executive vice president and CFO Doug Prince plans to leave MDS March 1.

"With the strategic repositioning of MDS under way, the board believes it is appropriate to move forward with its CEO transition plan," said James MacDonald, chairman of MDS' board of directors, in a company statement. "We are confident that Steve's attention to financial performance and his track record of strengthening operations will serve the company well, both now and into the future.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing